Rocket Lab USA press release ( RKLB ): Q4 GAAP EPS of -$0.09 beats by $0.01 . Revenue of $179.65M (+35.8% Y/Y) beats by $1.47M . For the first quarter of 2026, Rocket Lab expects: Revenue between $185 million and $200 million vs $180.88M consensus GAAP Gross Margins between 34% and 36%. Non-GAAP Gross Margins between 39% and 41%. GAAP Operating Expenses between $120 million and $126 million. Non-G...
Rocket Lab USA press release ( RKLB ): Q4 GAAP EPS of -$0.09 beats by $0.01 . Revenue of $179.65M (+35.8% Y/Y) beats by $1.47M . For the first quarter of 2026, Rocket Lab expects: Revenue between $185 million and $200 million vs $180.88M consensus GAAP Gross Margins between 34% and 36%. Non-GAAP Gross Margins between 39% and 41%. GAAP Operating Expenses between $120 million and $126 million. Non-GAAP Operating Expenses between $106 million and $112 million. Interest Income, net $8.0 million. Adjusted EBITDA loss of between $21 million and $27 million. Basic Weighted Average Common Shares Outstanding of 605 million, including approximately 46 million of Series A Convertible Participating Preferred Shares. Shares +1% . More on Rocket Lab USA Rocket Lab: Another Strong Quarter On The Horizon Rocket Lab: Bullish Catalysts Brewing Rocket Lab: Neutron Setback, Now An Opportunistic Rating Upgrade To Buy Rocket Lab USA Q4 2025 earnings preview: Strong revenue growth expected ULA investigates Vulcan rocket motor issue during Space Force launch
Payoneer Global Inc (PAYO) reports a 14% revenue growth and a significant shift towards AI-first strategies, despite facing challenges from market transitions and increased operating expenses.
Payoneer Global Inc (PAYO) reports a 14% revenue growth and a significant shift towards AI-first strategies, despite facing challenges from market transitions and increased operating expenses.
Wall Street closed lower on Thursday, as a lukewarm reaction to Nvidia’s ( NVDA ) fourth-quarter results and forward guidance weighed on sentiment and accelerated an ongoing market rotation. The chipmaker’s shares declined following the report, dampening enthusiasm across the broader technology complex. The tech-heavy Nasdaq Composite ( COMP:IND ) led the downturn, falling 1.1%, while the benchmar...
Wall Street closed lower on Thursday, as a lukewarm reaction to Nvidia’s ( NVDA ) fourth-quarter results and forward guidance weighed on sentiment and accelerated an ongoing market rotation. The chipmaker’s shares declined following the report, dampening enthusiasm across the broader technology complex. The tech-heavy Nasdaq Composite ( COMP:IND ) led the downturn, falling 1.1%, while the benchmark S&P 500 ( SP500 ) slid 0.5%. The blue-chip Dow Jones Industrial Average ( DJI ) finished near even. According to Seeking Alpha analyst Leo Nelissen, the session reflected a layered rotation beneath the surface. “Today was another great example of the rotation that has been going on, except it was multi-layered,” Nelissen said. “Not only did we see a move from tech to value areas like energy and industrials, but we even saw a move from semiconductors to software as a lot of money went into NVIDIA before its earnings.” He added that Nvidia’s pullback underscores a broader “sell the good news” dynamic, as investors continue reallocating capital toward cheaper value-oriented stocks after an extended run in mega-cap growth names. Market Tracking ETFs: ( DIA ), ( DDM ), ( DOG ), ( DXD ), ( SDOW ), ( SPY ), ( VOO ), ( IVV ), ( RSP ), ( SSO ), ( UPRO ), ( SH ), ( SDS ), ( SPXU ), ( QQQ ), ( QQQM ), ( TQQQ ), ( QID ), and ( SQQQ ). More on markets Dividend strength meets energy sector surge: Top 10 performers to watch Value or Growth? These 15 stocks are offering both S&P 500’s 20-day range squeeze near highs hints at imminent shift Powell may remain at the helm as traders shift Warsh confirmation timeline to the summer Nasdaq drops nearly 2% as the tech selloff deepens post Nvidia's earnings
Coupang press release ( CPNG ): Q4 Non-GAAP EPS of -$0.01 misses by $0.05 . Revenue of $8.8B (+10.4% Y/Y) misses by $290M . Adjusted EBITDA for the quarter was $267 million with a margin of 3.0%, down 226 bps from last year. 5.9 million shares of Class A common stock were repurchased during the quarter for an aggregate amount of $162 million. More on Coupang Coupang: Data Breach Costs Two Years Co...
Coupang press release ( CPNG ): Q4 Non-GAAP EPS of -$0.01 misses by $0.05 . Revenue of $8.8B (+10.4% Y/Y) misses by $290M . Adjusted EBITDA for the quarter was $267 million with a margin of 3.0%, down 226 bps from last year. 5.9 million shares of Class A common stock were repurchased during the quarter for an aggregate amount of $162 million. More on Coupang Coupang: Data Breach Costs Two Years Coupang: The 'Amazon' Of Korea Coupang: Down 20%, Buy, Sell Or Hold? (Rating Upgrade) Coupang Q4 2025 Earnings Preview Coupang slips as investors fret if the company could be a trade talks bargaining chip
MidCap Financial Investment press release ( MFIC ): Q4 NII of $0.39 beats by $0.04 . Total investment income of $78.36M (-4.6% Y/Y) misses by $0.51M . Net asset value (“NAV”) per share as of the end of the quarter was $14.18, compared to $14.66 as of September 30, 2025, representing a 3.3% decline primarily driven by a handful of investments predominantly from 2022 and earlier vintages More on Mid...
MidCap Financial Investment press release ( MFIC ): Q4 NII of $0.39 beats by $0.04 . Total investment income of $78.36M (-4.6% Y/Y) misses by $0.51M . Net asset value (“NAV”) per share as of the end of the quarter was $14.18, compared to $14.66 as of September 30, 2025, representing a 3.3% decline primarily driven by a handful of investments predominantly from 2022 and earlier vintages More on MidCap Financial Investment What's in store for BDCs in 2026? Seeking Alpha’s Quant Rating on MidCap Financial Investment Historical earnings data for MidCap Financial Investment Dividend scorecard for MidCap Financial Investment
Jack Dorsey’s Block is cutting 4,000 employees, reducing its workforce by nearly half as the financial technology firm places a bet on artificial intelligence changing the future of labor productivity. Block has been restructuring its business model and staffing since 2024 as the company’s stock has lagged. At the same time, the company has invested heavily in artificial intelligence tools to run ...
Jack Dorsey’s Block is cutting 4,000 employees, reducing its workforce by nearly half as the financial technology firm places a bet on artificial intelligence changing the future of labor productivity. Block has been restructuring its business model and staffing since 2024 as the company’s stock has lagged. At the same time, the company has invested heavily in artificial intelligence tools to run more efficiently, including building its own tool called Goose. The reduction in force, which was announced in a shareholder letter on Thursday, comes after rolling job eliminations that have often been tied to annual performance reviews . “We are taking bold and decisive action here, but we’re doing it from a position of strength,” Amrita Ahuja, chief financial officer, said in an interview with Bloomberg. “We’re doing it in a way that we believe positions us to move even faster for our customers.” After the announcement, Block’s stock jumped as much as 22% in extended trading. The move by Block is the latest indication of the havoc that new AI tools are wreaking on the economy and financial markets. In the shareholder letter, the company highlighted strong financial performance over 2025 including gross profit growth that more than doubled from the first quarter to the fourth quarter. Dorsey, the company’s co-founder, touted how the company has reignited growth of users of its peer-to-peer payments app Cash App, scaled its lending products and accelerated Square gross payment volume. Block reported gross profit of $10.36 billion in 2025, up 17% year-over-year. Dorsey wrote in his letter that his staff learned about the cuts on Thursday and that he believes many companies will ultimately have to make similar moves due to AI. “I don’t think we’re early to this realization,” he wrote. “I think most companies are late. Within the next year, I believe the majority of companies will reach the same conclusion and make similar structural changes. I’d rather get there honestly and...
Duolingo press release ( DUOL ): Q4 net income of $42M Revenue of $282.9M (+35.0% Y/Y) beats by $6.95M . Shares -9% . More on Duolingo Duolingo: The Market Is Misunderstanding The "SaaSpocalypse" The Duolingo Paradox: Market Clairvoyance - Or Overreaction Before Earnings AI Is Rocket Fuel For Duolingo Duolingo Q4 2025 Earnings Preview ClearBridge Small-Cap Growth trims Duolingo, Biohaven, QLYS; Ad...
Duolingo press release ( DUOL ): Q4 net income of $42M Revenue of $282.9M (+35.0% Y/Y) beats by $6.95M . Shares -9% . More on Duolingo Duolingo: The Market Is Misunderstanding The "SaaSpocalypse" The Duolingo Paradox: Market Clairvoyance - Or Overreaction Before Earnings AI Is Rocket Fuel For Duolingo Duolingo Q4 2025 Earnings Preview ClearBridge Small-Cap Growth trims Duolingo, Biohaven, QLYS; Adds PTGX, SSD, BETA, DYN in Q4
Fourth quarter revenue growth of 9% with organic growth of 5% Accelerating AMS/DRS fourth quarter organic growth to 22% Record 2025 cash generation with cash from operations of $640M and free cash flow of $436M Reduced net debt leverage to 2.7x Adjusted EBITDA
Fourth quarter revenue growth of 9% with organic growth of 5% Accelerating AMS/DRS fourth quarter organic growth to 22% Record 2025 cash generation with cash from operations of $640M and free cash flow of $436M Reduced net debt leverage to 2.7x Adjusted EBITDA
Alignment Healthcare press release ( ALHC ): Q4 GAAP EPS of -$0.05 beats by $0.10 . Revenue of $1.02B (+45.5% Y/Y) beats by $20M . Adjusted gross profit* was $124.9 million and loss from operations was $10.3 million Adjusted gross profit excludes depreciation and amortization of $7.8 million and selling, general, and administrative expenses of $125.8 million (which includes $11.5 million of equity...
Alignment Healthcare press release ( ALHC ): Q4 GAAP EPS of -$0.05 beats by $0.10 . Revenue of $1.02B (+45.5% Y/Y) beats by $20M . Adjusted gross profit* was $124.9 million and loss from operations was $10.3 million Adjusted gross profit excludes depreciation and amortization of $7.8 million and selling, general, and administrative expenses of $125.8 million (which includes $11.5 million of equity-based compensation). Adjusted gross profit also excludes an additional $1.6 million of equity-based compensation recorded within medical expenses Medical benefits ratio based on adjusted gross profit was 87.7% Adjusted EBITDA* was $11.4 million and net loss was $11.0 million More on Alignment Healthcare Alignment Healthcare, Inc. (ALHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Medicare Advantage growth reportedly slows down as UnitedHealth, CVS retreat Alignment Healthcare guides 2026 membership growth up to 27% Seeking Alpha’s Quant Rating on Alignment Healthcare Historical earnings data for Alignment Healthcare
Greggory DiSalvo/iStock via Getty Images Inspire Medical Systems closed up ~15% Thursday after KeyBanc Capital Markets said it sees CMS adding several codes covering the company's Inspire V implant for sleep apnea. KeyBanc cited information within the MLN Connects Newsletter dated Thursday dealing with new codes for hypoglossal nerve neurostimulators, effective Jan. 1, 2026. The six codes cover im...
Greggory DiSalvo/iStock via Getty Images Inspire Medical Systems closed up ~15% Thursday after KeyBanc Capital Markets said it sees CMS adding several codes covering the company's Inspire V implant for sleep apnea. KeyBanc cited information within the MLN Connects Newsletter dated Thursday dealing with new codes for hypoglossal nerve neurostimulators, effective Jan. 1, 2026. The six codes cover implantation, replacement, and removal of a n eurostimulator array and pulse generator. "CMS is aware of questions regarding coding for hypoglossal nerve neurostimulators for the treatment of obstructive sleep apnea and concerns that the current CPT codes don't accurately describe some newer hypoglossal nerve neurostimulators," the document states . "While still early, we are viewing this development as directionally positive, given it could expedite the pathway for gaining clarity into permanent and product-specific payment approaches," analysts Brett Fishbin and William Korner wrote. More on Inspire Medical Systems Inspire Medical: Still A Long Way From A Good Night's Sleep Inspire Medical Systems, Inc. (INSP) Q4 2025 Earnings Call Transcript Inspire Medical Systems, Inc. 2025 Q4 - Results - Earnings Call Presentation Inspire Medical Systems signals 2026 revenue outlook of $950M-$1B amid coding changes and reimbursement headwinds Despite Q4 beats, Inspire Medical declines on revised 2026 revenue outlook
Sunrun press release ( RUN ): Q4 GAAP EPS of $0.38 beats by $0.44 . Revenue of $1.16B (+123.7% Y/Y). Outlook Aggregate Subscriber Value is expected to be in a range of $850 million to $950 million in the first quarter of 2026. Contracted Net Value Creation is expected to be in a range of $25 million to $125 million in the first quarter of 2026. Cash Generation 2 is expected to be positive in the f...
Sunrun press release ( RUN ): Q4 GAAP EPS of $0.38 beats by $0.44 . Revenue of $1.16B (+123.7% Y/Y). Outlook Aggregate Subscriber Value is expected to be in a range of $850 million to $950 million in the first quarter of 2026. Contracted Net Value Creation is expected to be in a range of $25 million to $125 million in the first quarter of 2026. Cash Generation 2 is expected to be positive in the first quarter of 2026. For the full-year 2026, Aggregate Subscriber Value is expected to be in a range of $4.8 billion to $5.2 billion. Contracted Net Value Creation is expected to be in a range of $650 million to $1,050 million for the full-year 2026. Cash Generation 2 is expected to be in a range of $250 million to $450 million for the full-year 2026, excluding potential investment related to safe harbor strategies. Shares +14.25 AH. More on Sunrun The Market Is Missing Sunrun's Cash And Battery Boom Sunrun Q4 2025 Earnings Preview Most and least shorted industrial stocks with over $2B market cap Seeking Alpha’s Quant Rating on Sunrun Historical earnings data for Sunrun
Initiates Non-GAAP 30% Rule of 40 Target By the Fourth Quarter of 2027 Approximated Subscription Revenue Contribution for ≥$30K ARR Customers Grew 22% in 2025
Initiates Non-GAAP 30% Rule of 40 Target By the Fourth Quarter of 2027 Approximated Subscription Revenue Contribution for ≥$30K ARR Customers Grew 22% in 2025
REDWOOD CITY, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today reported financial results for the fourth quarter and full year ended December 31, 2025.
REDWOOD CITY, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today reported financial results for the fourth quarter and full year ended December 31, 2025.
FREMONT, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Cytek ® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the fourth quarter and year ended December 31, 2025.
FREMONT, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Cytek ® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the fourth quarter and year ended December 31, 2025.
GAITHERSBURG, Md., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the quarter and year ended December 31, 2025.
GAITHERSBURG, Md., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the quarter and year ended December 31, 2025.